PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases

Published 2008 View Full Article

Authors

Keywords

Journal

LEUKEMIA RESEARCH

Volume 32, Issue 12, Pages 1857-1865

Publisher

Elsevier BV

Online

2008-06-03

DOI

10.1016/j.leukres.2008.04.012

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

LEUKEMIA RESEARCH

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Become a Peeref-certified reviewer